FDA product code · Neurology

Inhibitor, Peridural Fibrosis (Adhesion Barrier)

Name: FDA decisions, review times, recalls and adverse event reports for product code MLQ
Creator: 510(k) Report

MLQClass IIIPMA required1 decision since 19980 recalls

1 FDA decision since 1998. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, neurology panel

Twenty years of MLQ at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · MLQ

FDA has decided no MLQ device since 2007.

Median 510(k) review, days · MLQ

Too few MLQ 510(k)s in any year since 2007 to give a median.

Recalls per year · MLQ

No recall names MLQ since 2007.

Adverse event reports per year · MLQ

1in 2008

2007high 1 (2008) · low 0 (2007)2025

MAUDE reports naming product code MLQ, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	1
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	0
2026	—	—

FIG. 1 — MLQ by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in MLQ? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Inhibitor, Peridural Fibrosis (Adhesion Barrier)

What has FDA decided in MLQ lately?